Tumor Biology and CRS/HIPEC Patients - UMass PMP/Appendiceal Cancer Symposium 2012

James Pingpank, Jr. MD discusses the Impact of Tumor Biology on Outcomes of Patients Undergoing CRS and HIPEC for Peritoneal Malignancies at the UMass PMP/Appendiceal Cancer Symposium - Worcester, MA - September 12, 2012
Attendees at this second annual event learned about pseudomyxoma peritonei and non-carcinoid appendiceal tumors and heard from a variety of experts about the prevalence, the signs and symptoms, treatment options, and latest research. Topics presented included surgical and medical oncology perspectives, imaging for appendiceal cancer, insurance coverage, nutrition, exercise and wellness, and patient and family perspectives.